RecruitingNot ApplicableNCT04557618
Auricular VNS Following Subarachnoid Hemorrhage
Transcutaneous Auricular Vagus Nerve Stimulation Following Spontaneous Subarachnoid Hemorrhage
Sponsor
Anna Huguenard
Enrollment
50 participants
Start Date
Jan 5, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Spontaneous subarachnoid hemorrhage
Exclusion Criteria5
- Trauma-induced subarachnoid hemorrhage
- Ongoing chemotherapy
- Taking immunosuppressive medications for other medical illnesses
- Presence of a pacemaker
- Prolonged bradycardia at time of admission
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAuricular Vagus Nerve Stimulation
Transcutaneous auricular vagal nerve stimulation
DEVICESham Auricular Vagus nerve Stimulation
Transcutaneous auricular vagal nerve ear clip applied without current
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04557618
Related Trials
Neurosurgical Outcome Network
NCT0672402927 locations
Ventilatory Parameters in Acute Neurological Injury
NCT061923421 location
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
NCT050017501 location
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
NCT040435983 locations
Effect of the Stellate Ganglion Block on the Retinal Microcirculation
NCT067977521 location